Legal & General Group’s CG Oncology CGON Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.15M | Buy |
44,354
+4,847
| +12% | +$126K | ﹤0.01% | 2192 |
|
|
2025
Q1 | $968K | Buy |
39,507
+10,245
| +35% | +$251K | ﹤0.01% | 2198 |
|
|
2024
Q4 | $839K | Buy |
29,262
+4,865
| +20% | +$140K | ﹤0.01% | 2300 |
|
|
2024
Q3 | $921K | Buy |
24,397
+5,262
| +27% | +$199K | ﹤0.01% | 2261 |
|
|
2024
Q2 | $604K | Buy |
19,135
+16,973
| +785% | +$536K | ﹤0.01% | 2351 |
|
|
2024
Q1 | $94.8K | Buy |
+2,162
| New | +$94.8K | ﹤0.01% | 2739 |
|